Population monitoring for cancer research consists of the frequent (or even continuous) gathering of information in a given population that is relevant to that population's cancer risk. This ranges from information on exposure (such as real-time monitoring of radiation dose in a population of radiation workers) or carcinogeninduced phenotypic changes or adducts to information on gene mutations, possible preneoplastic lesions (screening for breast or thyroid abnormalities in the general population or in a high-risk population), and cancer occurrence (monitoring of cancer incidence or mortality through population registries in a geographical area epidemiological studies (with well-defined objectives), with sufficient power, and with information on all factors of interest, including quantitative data on exposure, individual response to exposure, and genetic background. This will allow an assessment of the usefulness of specific biological markers as predictors of exposure and cancer risk and, most importantly, the study of genetic susceptibility to cancer induced by environmental mutagens and of phenotypic response to these agents. This will also avoid, or minimize, indiscriminate collection of data and biological samples without a specific research objective, which (as discussed throughout this conference) can give rise to erroneous interpretations. Finally, it will increase the cost-effectiveness of studies of biomarkers.
In the planning and conduct of such studies, careful consideration must be given to standardizing study parameters (4, 5) .
In conclusion, the careful use of biomarkers in future large-scale, well-designed studies will most certainly lead to major improvement in our understanding of the mechanisms of carcinogenesis and thus have important cancer preventive and public health consequences.
